Public Acquisition Corporation Acquires Wound Care Company
Avista Healthcare Public Acquisition Corp (New York, NY), a publicly traded special purpose acquisition company, has reached a definitive merger agreement with Organogenesis, Inc (Canton, MA). In this agreement, the regenerative medicine company will become a wholly owned subsidiary of the publicly traded special purpose acquisition company. The deal is funded through a combination of cash, stock, and rollover debt financing. Additionally, as part of the agreement, affiliates of Avista Capital Partners (New York, NY) has agreed to invest $92 million into the combined company.
Visit www.organogenesis.com for more information.